SCHEMBL8335678

SCHEMBL8335678

NC(=O)c1cc(Br)ccc1OCCN1CCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 5/20 0.54
GAA P10253 2/20 0.54
POLB P06746 1/20 0.54
HTR1B P28222 1/20 0.53
TDP1 Q9NUW8 1/20 0.51
DRD2 P14416 1/20 0.50
DRD1 P21728 1/20 0.50
DRD3 P35462 1/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
ABCB1 P08183 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
LTA4H P09960 1/20 0.47
PTGS2 P35354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8338047 0.88 ALDH1A1 (0.66) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL2804626 0.83 DRD2 (0.54) MEN1KMT2AKDM4EGAADRD2
SCHEMBL8338923 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EPOLBTDP1MAPT
SCHEMBL876068 0.81 DRD2 (0.69) MEN1KMT2AKDM4EGAATDP1
SCHEMBL8334830 0.81 KMT2A (0.49) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL27040260 0.78 HTR1B (0.75) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL16997486 0.78 PTGDR2 (0.48) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL2322967 0.78 HTR1B (0.67) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL226018 0.77 LTA4H (0.60) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL227430 0.77 LTA4H (0.60) MEN1KMT2AALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014844-A2 ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION TRANSTECH PHARMA, INC. (US) 2004-02-19 WO disclosed